SYSTEMATIC REVIEW article
Front. Immunol.
Sec. T Cell Biology
This article is part of the Research TopicEpigenetic Regulation of T Cell Function in Type 1 DiabetesView all 4 articles
The Role of microRNAs and Long Non-coding RNAs in Epigenetic Regulation of T Cells: Implications for Autoimmunity
Provisionally accepted
Soumil Prasad1Harini Adivikolanu1Abhinav Banerjee1Mannat Mittal1Joana RN Lemos1
Rahul Mittal2*
Khemraj Hirani1- 1University of Miami Miller School of Medicine, Miami, United States
- 2Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract Non-coding RNAs (ncRNAs), comprising microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are increasingly recognized as central regulators of epigenetic programming in T lymphocytes with critical implications for immune tolerance and autoimmunity. We conducted a systematic review to investigate the influence of non-coding RNAs on DNA methylation, histone modifications, and chromatin accessibility in T cells across diverse autoimmune diseases. The majority of studies identified consistent patterns of dysregulation, including increased expression of miR21, miR148a, and miR155, and decreased expression of miR146a, GAS5, and IL21AS1. These alterations were associated with hypomethylation of proinflammatory gene loci, reduction of repressive histone marks, and increased chromatin accessibility at promoters of genes driving pathogenic T cell responses. Mechanistic data from both human and animal models demonstrated that microRNAs frequently regulate the abundance or activity of DNA methyltransferases and upstream signaling molecules, whereas long non-coding RNAs influence the recruitment or activity of chromatin modifying complexes, serve as scaffolds for transcriptional regulators, or function as competitive endogenous RNAs. Experimental manipulation of these non-coding RNAs attenuated disease-associated epigenetic and functional changes in T cells, supporting a causal role in autoimmune pathogenesis. Collectively, the non-coding RNAs as potential biomarkers of disease activity and as therapeutic targets capable of restoring physiological epigenetic regulation in a cell type specific manner. Future research should prioritize longitudinal and single cell multiomics approaches to delineate the dynamic interactions between non-coding RNAs and the chromatin landscape in order to accelerate the translation of these findings into targeted RNA based interventions for autoimmune diseases.
Keywords: T cells, Autoimmunity, epigenetics, microRNA, long non-coding RNA, type 1 diabetes
Received: 30 Aug 2025; Accepted: 31 Oct 2025.
Copyright: © 2025 Prasad, Adivikolanu, Banerjee, Mittal, Lemos, Mittal and Hirani. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Rahul Mittal, r.mittal11@med.miami.edu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.